An Open-label, Single Dose Study to Assess Intrapulmonary Pharmacokinetics of ME1100 Inhalation Solution Administered to Healthy Volunteers
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Arbekacin (Primary)
- Indications Nosocomial pneumonia
- Focus Pharmacokinetics
- Sponsors Meiji Seika Pharma
- 10 Jun 2019 Population pharmacokinetic results from ME1100-CL-102, ME1100-CL-103 and post-marketing study were published in the Antimicrobial Agents and Chemotherapy.
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 09 Sep 2014 Results of a pooled analysis of this trial and a single ascending dose trial were presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy.